Filter
779
Text search:
clinical
trials
Featured
Recommendations
84
New Publications
123
Language
Document type
No document type
386
Guidelines
159
Studies & Reports
122
Manuals
38
Fact sheets
30
Strategic & Response Plan
17
Training Material
12
Resource Platforms
7
Situation Updates
4
Infographics
3
Brochures
1
Countries / Regions
India
38
Global
30
South Africa
19
Africa
14
Kenya
13
Western and Central Europe
10
Uganda
9
Rwanda
9
Latin America and the Carribbean
8
Ukraine
7
Eastern Europe
7
Russia
7
Sierra Leone
6
Ethiopia
6
Malawi
6
East and Southern Africa
6
South–East Asia Region
6
Liberia
5
Congo, Democratic Republic of
5
Ghana
5
Brazil
5
West and Central Africa
5
Guinea
4
Nigeria
4
Cameroon
4
Zimbabwe
4
Philippines
4
Tanzania
4
Bangladesh
4
USA
3
Nepal
3
Germany
3
Namibia
3
Botswana
3
Chile
3
Middle East and North Africa
3
Indonesia
2
Eswatini/ Swaziland
2
Albania
2
Tajikistan
2
Spain
2
Senegal
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
Haiti
1
South Sudan
1
Lebanon
1
Zambia
1
Turkey
1
Syria
1
Chad
1
China
1
Mozambique
1
Sudan
1
Argentina
1
Colombia
1
Angola
1
Lesotho
1
Sri Lanka
1
Asia
1
Laos
1
Estonia
1
Moldova
1
Kyrgyzstan
1
Kazakhstan
1
Vietnam
1
North America
1
Denmark
1
France
1
United Kingdom
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
164
Clinical Guidelines
116
Women & Child Health
59
Public Health
50
Key Resources
16
Pharmacy & Technologies
14
Capacity Building
7
Toolboxes
Mental Health
114
COVID-19
94
HIV
78
TB
64
NTDs
39
AMR
32
NCDs
31
Caregiver
23
Ebola & Marburg
20
Pharmacy
19
Disability
14
Rapid Response
11
Polio
7
Malaria
7
Global Health Education
6
Planetary Health
6
Refugee
5
Zika
5
Cholera
4
2.0 Rapid Response
3
Health Financing Toolbox
2
Conflict
1
Natural Hazards
1
Specific Hazards
1
Social Ethics
1
Print version ISSN 1809-9823On-line version ISSN 1981-2256
Rev. bras. geriatr. gerontol. vol.19 no.2 Rio de Janeiro Mar./Apr. 2016
http://dx.doi.org/10.1590/1809-98232016019.150040
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir
...
Canadian Journal of Microbiology 25 June 2021 https://doi.org/10.1139/cjm-2020-0572
Human African trypanosomiasis (HAT), or sleeping sickness, is an endemic disease in 36 sub-Saharan African countries, typically occurring in underdeveloped areas, where
health systems face significant difficulties of diverse natures.
This document facilitate the preparation of a risk communication and community engagement strategy for vaccination against COVID-19. Its goal is to help to strengthen the communication and planning capacities of the ministries or secretariats of health and other agencies in charge of communicating
...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Tuberculosis (TB)
recommended
MEDBOX Issue Brief no. 19: World TB Day: Invest to end TB. Save Lives
SECOND MEETING REPORT
DECATUR, GA, USA, 26 JUNE 2016
The article "Barriers and determinants of asthma control in children and adolescents in Africa: a systematic review" analyzes factors contributing to poor asthma control in African youth. Based on studies conducted between 2014 and 2019 in Nigeria, Uganda, and South Africa, the review identifies key
...
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, however, particularly the poorest segment. In fact, the p
...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect
...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher
...
Research
Emerging Infectious Diseases Vol. 12, No. 5, May 2006
Technical specifications series for submission to WHO prequalification: diagnostic assessment;TSS-3
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these
...
Cochrane Database Syst Rev. 2016 Jul 1; (6): 1–61 -Published online 2016 July 1
Leishmaniasis is a climate-sensitive disease. Changes in temperature, rainfall, and humidity can have strong impacts on
the sandfly vector, altering their distribution and influencing their survival and population sizes. Increased temperatures shorten vector development time, reduce Leishmania para
...
